알림

Oramed Pharmaceuticals In... (ORMP)

NasdaqCM: ORMP · 실시간 가격 · USD

4.38

+0.11 (2.58%)

종가 기준: Aug 13, 2026, 3:59 PM

2.58% (1D)

매수호가	3.14
시가총액	182.2M
매출 (ttm)	n/a
순이익 (ttm)	174.06M
베타	1.16
EPS (ttm)	4.24
P/E (ttm)	1.06
선행 P/E	-54.75
P/B (ttm)	0.57
P/S (ttm)	n/a
Earnings Date	Nov 12, 2026

매도호가	5.55
거래량	150,083
평균 거래량 (20일)	295,298
시가	4.35
전일 종가	4.27
일중 범위	4.30 - 4.45
52주 범위	1.98 - 5.19
애널리스트	n/a
목표주가	6.25 (42.69%)
배당	$0.25 (5.85%)
배당락일	2026년 1월 16일

ORMP 소개

Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions with a technology platform for the oral delivery of therapeutic proteins. It develops ORMD-0801, an oral insulin capsule, which is in phase III clinical trial for the treatment of individuals with diabetes. The company has license agreements with Oravax Medical Inc. to commercialize oral vaccines for COVID-19. Oramed Pharmaceuticals Inc. was incorporat...

[더 보기]

산업 Biotechnology

섹터 Healthcare

IPO 일자 May 1, 2007

직원 수 n/a

상장 거래소 NasdaqCM

티커 ORMP

웹사이트 https://oramed.com

전체 기업 정보

재무 실적

2025년 Oramed Pharmaceuticals의 매출은 2M로, 전년 0 대비 undefined% 증가했습니다. 순이익은 64.05M로, -436.04% 감소했습니다.

재무제표

애널리스트 전망

애널리스트 1명의 투자의견을 종합하면 ORMP 주식의 평균 등급은 "null"입니다. 12개월 목표주가는 6.25로, 최근 주가 대비 42.69% 상승 여력입니다.

주가 전망

어닝 서프라이즈

Oramed Pharmaceuticals가 Aug 10, 2026에 분기 실적을 발표했습니다:

매출 $0 예상치 하회 $0, 및 -100.00% 전년 대비 감소.

EPS 1.84 예상치 상회 1.41, 및 1068.42% 전년 대비 성장.

다음 실적 발표

Oramed Pharmaceuticals Inc.의 실적 발표 예정일은 Nov 12, 2026, 정규장 중입니다.
애널리스트 예상 매출은 ... 업그레이드

뉴스

1개월 전 · Simply Wall St.

June 2026 Penny Stocks To Watch For Potential Growth

Over the last 7 days, the market has remained flat, but it is up 24% over the past year, with earnings expected to grow by 19% per annum over the next few years. For investors willing to explore beyon...

3개월 전 · Simply Wall St.

Spotlight On Oramed Pharmaceuticals And Two Other Prominent Penny Stocks

The market has climbed 1.5% in the last 7 days and is up 26% over the last 12 months, with earnings forecast to grow by 17% annually. While the term 'penny stock' might seem outdated, these investment...

4개월 전 · Simply Wall St.

Oramed Pharmaceuticals And Two Other Promising Penny Stocks For Savvy Investors

The market has shown impressive growth, with a 4.2% increase over the last week and a 29% rise over the past year, while earnings are projected to grow by 16% annually. Although the term 'penny stock'...

4개월 전 · Associated Press Finance

Oramed: Q4 Earnings Snapshot

NEW YORK (AP) — Oramed Pharmaceuticals Inc. ORMP) on Thursday reported profit of $10 million in its fourth quarter. The New York-based company said it had net income of 24 cents per share.

6개월 전 · Motley Fool

CarMax Stock Down 47% This Past Year, But One Fund Is Betting $6 Million on a Turnaround

CarMax runs a nationwide network of used car stores and digital channels, offering multi-channel sales and financing to U.S. consumers.

2 페이지 중 1